CA2373603A1 - Composes diphenylethylene innovants - Google Patents

Composes diphenylethylene innovants Download PDF

Info

Publication number
CA2373603A1
CA2373603A1 CA002373603A CA2373603A CA2373603A1 CA 2373603 A1 CA2373603 A1 CA 2373603A1 CA 002373603 A CA002373603 A CA 002373603A CA 2373603 A CA2373603 A CA 2373603A CA 2373603 A1 CA2373603 A1 CA 2373603A1
Authority
CA
Canada
Prior art keywords
ome
compound
hydrogen
composition according
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002373603A
Other languages
English (en)
Inventor
Bishwajit Nag
Satyanarayana Medicherla
Debendranath Dey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calyx Therapeutics Inc
Original Assignee
Calyx Therapeutics, Inc.
Bishwajit Nag
Satyanarayana Medicherla
Debendranath Dey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calyx Therapeutics, Inc., Bishwajit Nag, Satyanarayana Medicherla, Debendranath Dey filed Critical Calyx Therapeutics, Inc.
Publication of CA2373603A1 publication Critical patent/CA2373603A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/40—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals
    • C07C15/50—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic non-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
CA002373603A 1999-05-18 1999-05-18 Composes diphenylethylene innovants Abandoned CA2373603A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/011001 WO2000069430A1 (fr) 1999-05-18 1999-05-18 Composes diphenylethylene innovants

Publications (1)

Publication Number Publication Date
CA2373603A1 true CA2373603A1 (fr) 2000-11-23

Family

ID=22272785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002373603A Abandoned CA2373603A1 (fr) 1999-05-18 1999-05-18 Composes diphenylethylene innovants

Country Status (9)

Country Link
EP (1) EP1178788A4 (fr)
JP (1) JP2002544227A (fr)
KR (1) KR100598638B1 (fr)
CN (1) CN1194674C (fr)
AU (1) AU778767C (fr)
CA (1) CA2373603A1 (fr)
HK (1) HK1046642B (fr)
MX (1) MXPA01011760A (fr)
WO (1) WO2000069430A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323496B2 (en) 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
JP2003521500A (ja) * 2000-02-04 2003-07-15 カリックス セラピューティックス インコーポレイテッド 新規ジフェニルエチレン化合物
US6552085B2 (en) 2000-08-16 2003-04-22 Insmed Incorporated Compositions containing hypoglycemically active stilbenoids
US6410596B1 (en) * 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids
US7384920B2 (en) 2001-07-26 2008-06-10 Institute Of Radiation Medicine, Academy Of Military Medical Sciences, Pla Use of stilbene compounds in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus-associated diseases
JP4781580B2 (ja) * 2001-09-26 2011-09-28 日本メナード化粧品株式会社 コラゲナーゼ阻害剤
JP2007527418A (ja) 2003-12-29 2007-09-27 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 肥満及びインシュリン耐性障害を治療又は防止するための組成物
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
CN1723884A (zh) * 2004-07-21 2006-01-25 中国人民解放军军事医学科学院放射医学研究所 顺式－1，2－取代的二苯乙烯衍生物用于制备治疗或预防糖尿病的药物的用途
WO2006138418A2 (fr) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Amelioration de la performance cognitive avec des activateurs de sirtuine
CN100384801C (zh) * 2006-06-23 2008-04-30 中国科学院广州化学研究所 (e)-3,5-二甲氧基-4＇-羟基二苯乙烯的合成方法
FR2904311B1 (fr) 2006-07-28 2013-01-11 Clariant Specialty Fine Chem F Nouveau procede de synthese de derives (e) stilbeniques perm permettant d'obtenir le resveratrol et le piceatannol
FR2921921B1 (fr) 2007-10-03 2011-08-19 Clariant Specialty Fine Chem F Procede de synthese de composes polyhydroxystilbeniques.
CN107324976B (zh) * 2017-07-28 2020-06-16 安徽理工大学 一种制备(E)-β-烷基苯乙烯类化合物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314693A (en) * 1992-02-07 1994-05-24 Kioritz Corporation Pest control chemicals against pine wood nematodes
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
US5770620A (en) * 1995-06-19 1998-06-23 Ontogen Corporation Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures

Also Published As

Publication number Publication date
EP1178788A4 (fr) 2005-08-10
CN1354659A (zh) 2002-06-19
CN1194674C (zh) 2005-03-30
AU4085799A (en) 2000-12-05
HK1046642A1 (en) 2003-01-24
EP1178788A1 (fr) 2002-02-13
JP2002544227A (ja) 2002-12-24
WO2000069430A1 (fr) 2000-11-23
HK1046642B (zh) 2005-11-25
KR100598638B1 (ko) 2006-07-07
KR20020012220A (ko) 2002-02-15
AU778767B2 (en) 2004-12-23
AU778767C (en) 2006-09-07
MXPA01011760A (es) 2003-09-04

Similar Documents

Publication Publication Date Title
US6245814B1 (en) Diphenylethylene compounds
US5827898A (en) Use of bisphenolic compounds to treat type II diabetes
AU778767C (en) Novel diphenylethylene compounds
US6624197B1 (en) Diphenylethylene compounds
CA2637884A1 (fr) Composes pour le traitement de troubles du metabolisme
US6448450B1 (en) 1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatment
WO1996039133A1 (fr) Nouvelles 2-amino-3'-4'-methylene-dioxypropiophenones n-substituees
US6855732B2 (en) Compounds to treat diabetes and associated conditions
US20040259938A1 (en) Novel dipheylenthylene compounds
KR101391905B1 (ko) 물질대사 장애의 치료용 화합물
NZ511065A (en) Diphenylethylene (stillbenzenes) compounds for treating diabetes
AU784974B2 (en) Novel diphenylethylene compounds
CA2487165C (fr) Dimeres d'acide cinamique, preparation associee et utilisation correspondante dans le traitement des maladies neurodegeneratives
KR20020084110A (ko) 신규한 디페닐에틸렌 화합물
EP0080011A1 (fr) Composés à activité anti-inflammatoire et analgésique, procédé pour leur préparation et les compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead